Functional influenza virus like particles (VLPs)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9694066
SERIAL NO

14733632

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses and claims virus like particles (VLPs) that express and/or contains seasonal influenza virus proteins, avian influenza virus proteins and/or influenza virus proteins from viruses with pandemic potential. The invention includes vector constructs comprising said proteins, cells comprising said constructs, formulations and vaccines comprising VLPs of the inventions. The invention also includes methods of making and administrating VLPs to vertebrates, including methods of inducing substantial immunity to either seasonal and avian influenza, or at least one symptom thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVAVAX INC21 FIRSTFIELD ROAD GAITHERSBURG MD 20878

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bright, Rick Washington, US 12 229
Mahmood, Kutub Cupertino, US 15 283
Pushko, Peter M Rockville, US 18 405
Smith, Gale Rockville, US 70 738
Zhang, Jinyou Plainsboro, US 15 241

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 4, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00